¼¼°èÀÇ ÀçÁ¶ÇÕ ´Ü¹éÁú ½ÃÀå : Á¦Ç° À¯Çüº°, ¹ßÇö ½Ã½ºÅÛº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Recombinant Protein Market, by Product Type, by Expression System, by Application, by End User, by Region
»óǰÄÚµå : 1789444
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,365,000
Unprintable PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,901,000
PDF & Excel (Multi User License - Up to 7 Users) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ÃÖ´ë 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,145,000
PDF & Excel (Corporate User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù. Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀçÁ¶ÇÕ ´Ü¹éÁú ½ÃÀåÀº 2025³â¿¡´Â 38¾ï 9,250¸¸ ´Þ·¯, 2032³â¿¡´Â 83¾ï 3,970¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2032³â CAGRÀº 11.5%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 38¾ï 9,250¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â 11.50% 2032³â ±Ý¾× ¿¹Ãø 83¾ï 3,970¸¸ ´Þ·¯

ÀçÁ¶ÇÕ ´Ü¹éÁúÀº À¯ÀüÀÚ ¹ßÇö°ú ¸Þ½ÅÀú RNAÀÇ ¹ø¿ªÀ» Áö¿øÇÏ´Â ¹ßÇö º¤ÅÍ¿¡ º¹Á¦µÈ ÀçÁ¶ÇÕ DNA¿¡ ÀÇÇØ ÄÚµåÈ­µÈ ´Ü¹éÁúÀÔ´Ï´Ù. ÀçÁ¶ÇÕ DNA ±â¼ú¿¡ ÀÇÇÑ À¯ÀüÀÚ º¯ÇüÀº µ¹¿¬º¯ÀÌ ´Ü¹éÁúÀÇ ¹ßÇöÀ» ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀçÁ¶ÇÕ ´Ü¹éÁúÀº ´Ü¹éÁú »ý»êÀ» Áõ°¡½Ã۰í, À¯ÀüÀÚ ¼­¿­À» º¯°æÇϰí, À¯¿ëÇÑ »óǰÀ» »ý»êÇϱâ À§ÇØ ´Ù¾çÇÑ ¹æ¹ýÀ¸·Î »ý»êµÈ õ¿¬ ´Ü¹éÁúÀÇ Á¶ÀÛµÈ ÇüÅÂÀÔ´Ï´Ù.

¸¹Àº ÀçÁ¶ÇÕ ´Ü¹éÁúÀº ÁøÇÙ»ý¹°, È¿¸ð, Æ÷À¯·ù, Æ÷À¯·ù, °ïÃæÀÇ ¼¼Æ÷ ¹è¾ç ½Ã½ºÅÛ¿¡¼­¸¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ±Û¸®ÄÚ½ÇÈ­ µîÀÇ ¹ø¿ª ÈÄ º¯ÇüÀÌ ÇÊ¿äÇϸç, À̸¦ ±â¼úÇϰí ÀÖ½À´Ï´Ù. ÀϽÃÀûÀÎ ´Ü¹éÁú »ý»ê¿¡´Â HEK293 À¯·¡ ¼¼Æ÷ÁÖ°¡ »ç¿ëµË´Ï´Ù. ÇöÀç ´ëºÎºÐÀÇ ÀçÁ¶ÇÕ Ä¡·á¿ë ´Ü¹éÁúÀº ÀÚ¿¬°è¿¡ Á¸ÀçÇÏ´Â °Í°ú À¯»çÇÑ °íǰÁú ´Ü¹éÁúÀ» »ý»êÇÒ ¼ö ÀÖ´Â Æ÷À¯·ù ¼¼Æ÷¿¡¼­ »ý»êµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¹Àº ½ÂÀÎµÈ ÀçÁ¶ÇÕ Ä¡·á¿ë ´Ü¹éÁúÀº ´ëÀå±ÕÀ¸·Î »ý»êµÇ°í ÀÖ½À´Ï´Ù. ±× ÀÌÀ¯´Â À¯ÀüÇÐÀûÀ¸·Î Àß Æ¯¼ºÈ­µÇ¾î ÀÖ°í, Áõ½ÄÀÌ ºü¸£¸ç, ³ôÀº ¼öÀ²·Î »ý»êÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ

ÀÌ È¸»ç´Â ¼¼°è ½ÃÀå¿¡¼­ źźÇÑ °ñ°ÝÀ» ±¸ÃàÇϱâ À§ÇØ Àμö ¹× Á¦ÈÞ µîÀÇ Àü·«À» äÅÃÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 12¿ù Thermo Fisher ScientificÀº ÀçÁ¶ÇÕ ´Ü¹éÁú °³¹ß ¹× Á¦Á¶ ȸ»çÀÎ ÆäÇÁ·ÎÅØ(Peprotech)À» ÀμöÇß½À´Ï´Ù. À̹ø Àμö·Î Thermo Fisher ScientificÀº ÀçÁ¶ÇÕ ´Ü¹éÁú Æ÷Æ®Æú¸®¿À¸¦ °­È­ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

±ÔÁ¦ ´ç±¹ÀÇ ÀçÁ¶ÇÕ È£¸£¸ó »ý¹°ÇÐÀû Á¦Á¦ Çã°¡ ½Åû¿¡ ´ëÇÑ ½ÂÀÎ Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 1¿ù, ´Ù±¹Àû Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷ÀÎ Pfizer Inc.¿Í »ý¸í°øÇÐ ±â¾÷ÀÎ OPKO Health, Inc.´Â ¹Ì±¹ ½ÄǰÀǾ౹(FDA)ÀÌ ¼Ò¸¶Æ®·Î°ïÀÇ »ý¹°ÇÐÀû Á¦Á¦ Çã°¡ ½Åû(BLA)¿¡ ´ëÇÑ ½É»ç ¿Ï·á º¸°í¼­(CRL)¸¦ ¹ßÇàÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ¹ßÇ¥Çß½À´Ï´Ù. ¼Ò¸¶Æ®·Î°ïÀº ¼Ò¾Æ ¼ºÀåÈ£¸£¸ó ºÐºñºÎÀüÁõ(GHD) Ä¡·á¸¦ ÀûÀÀÁõÀ¸·Î ÇÏ´Â ÁÖ 1ȸ Åõ¿©ÇÏ´Â Àå½Ã°£ Áö¼ÓÇü À¯ÀüÀÚ ÀçÁ¶ÇÕ Àΰ£¼ºÀåÈ£¸£¸óÁ¦Á¦ÀÔ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ÀçÁ¶ÇÕ ´Ü¹éÁú ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â

Á¦5Àå ¼¼°èÀÇ ÀçÁ¶ÇÕ ´Ü¹éÁú ½ÃÀå, ¹ßÇö ½Ã½ºÅÛº°, 2020-2032³â

Á¦6Àå ¼¼°èÀÇ ÀçÁ¶ÇÕ ´Ü¹éÁú ½ÃÀå, ¿ëµµº°, 2020-2032³â

Á¦7Àå ¼¼°èÀÇ ÀçÁ¶ÇÕ ´Ü¹éÁú ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

Á¦8Àå ¼¼°èÀÇ ÀçÁ¶ÇÕ ´Ü¹éÁú ½ÃÀå, Áö¿ªº°, 2020-2032³â

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¼½¼Ç

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Recombinant Protein Market is estimated to be valued at USD 3,892.5 Mn in 2025 and is expected to reach USD 8,339.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3,892.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.50% 2032 Value Projection: USD 8,339.7 Mn

A recombinant protein is a protein encoded by recombinant DNA cloned into an expression vector that supports gene expression and translation of messenger RNA. Modification of genes by recombinant DNA techniques can result in the expression of mutant proteins. Recombinant proteins are engineered forms of natural proteins that are produced in a variety of ways to increase protein production, alter genetic sequences, and produce useful commodities.

Many recombinant proteins require and provide post-translational modifications such as glycosylation, which are only available in eukaryotic, yeast, mammalian and insect cell culture systems. HEK293-derived cell lines are used for transient protein production. Currently, most recombinant therapeutic proteins are produced in mammalian cells due to their ability to produce high quality proteins similar to those in nature. In addition, many approved recombinant therapeutic proteins have been produced in E. coli due to well-characterized genetics, rapid growth, and high-yield production.

Market Dynamics

The company is focused on adopting strategies such as acquisitions and collaborations to gain strong foothold in the global market. For instance, in December, 2021, Thermo Fischer Scientific Inc. acquired PeproTech, Inc., which is a developer and manufacturer of recombinant proteins. This acquisition will help Thermo Fischer Scientific Inc. to strengthen its recombinant proteins portfolio.

The increasing approvals for the biologics license application of recombinant hormones from the regulatory bodies is expected to drive the market growth over the forecast period. For instance, in January 2022, Pfizer Inc., a multinational pharmaceutical and biotechnology Company, and OPKO Health, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the treatment of growth hormone deficiency (GHD) in pediatric patients.

Key features of the study

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Recombinant Protein Market, By Product Type, 2020 - 2032, (USD Mn)

5. Global Recombinant Protein Market, By Expression System, 2020 - 2032, (USD Mn)

6. Global Recombinant Protein Market, By Application, 2020 - 2032, (USD Mn)

7. Global Recombinant Protein Market, By End User, 2020 - 2032, (USD Mn

8. Global Recombinant Protein Market, By Region, 2020 - 2032, (USD Mn)

9. Competitive Landscape

10. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â